11-64607473-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015080.4(NRXN2):c.4862G>A(p.Gly1621Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000033 in 1,606,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015080.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NRXN2 | NM_015080.4 | c.4862G>A | p.Gly1621Asp | missense_variant | 23/23 | ENST00000265459.11 | NP_055895.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NRXN2 | ENST00000265459.11 | c.4862G>A | p.Gly1621Asp | missense_variant | 23/23 | 5 | NM_015080.4 | ENSP00000265459.5 | ||
NRXN2 | ENST00000704782.1 | c.4871G>A | p.Gly1624Asp | missense_variant | 22/22 | ENSP00000516031.1 | ||||
NRXN2 | ENST00000704781.1 | c.4289G>A | p.Gly1430Asp | missense_variant | 22/22 | ENSP00000516029.1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151318Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000301 AC: 7AN: 232878Hom.: 0 AF XY: 0.0000234 AC XY: 3AN XY: 128196
GnomAD4 exome AF: 0.0000213 AC: 31AN: 1455198Hom.: 0 Cov.: 33 AF XY: 0.0000180 AC XY: 13AN XY: 723738
GnomAD4 genome AF: 0.000145 AC: 22AN: 151318Hom.: 0 Cov.: 30 AF XY: 0.000189 AC XY: 14AN XY: 73898
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The c.4862G>A (p.G1621D) alteration is located in exon 23 (coding exon 22) of the NRXN2 gene. This alteration results from a G to A substitution at nucleotide position 4862, causing the glycine (G) at amino acid position 1621 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at